Explore Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 10, 2024Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer3
Jul 26, 2023Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination1
Apr 26, 2023Individualized Vaccines For Cancer1
Jul 6, 2022Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer2
Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell Epitopes1
Sep 8, 2021Individualized Vaccines For Cancer1
Sep 9, 2020Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer1
Sep 2, 2020Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes1
Jul 10, 2019Individualized Vaccines For Cancer3